121 related articles for article (PubMed ID: 8741318)
1. Improvement of bone disease with increased dose of glucocerebrosidase in a Gaucher disease patient who had a bone lesion presenting during low-dose enzyme replacement therapy.
Ueda T; Fukunaga Y; Migita M; Watanabe A; Kaneko K; Morita T; Yamamoto M
Acta Paediatr Jpn; 1996 Jun; 38(3):260-4. PubMed ID: 8741318
[TBL] [Abstract][Full Text] [Related]
2. Progression of bone disease without deterioration of hematological parameters in a child with Gaucher disease during low-dose glucocerebrosidase therapy.
Migita M; Fukunaga Y; Ueda T; Watanabe A; Morita T; Yamamoto M
Nihon Ika Daigaku Zasshi; 1994 Nov; 61(6):633-7. PubMed ID: 7829657
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.
Altarescu G; Schiffmann R; Parker CC; Moore DF; Kreps C; Brady RO; Barton NW
Blood Cells Mol Dis; 2000 Aug; 26(4):285-90. PubMed ID: 11042029
[TBL] [Abstract][Full Text] [Related]
4. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
5. Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1.
Andersson H; Kaplan P; Kacena K; Yee J
Pediatrics; 2008 Dec; 122(6):1182-90. PubMed ID: 19047232
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.
Weinreb NJ; Charrow J; Andersson HC; Kaplan P; Kolodny EH; Mistry P; Pastores G; Rosenbloom BE; Scott CR; Wappner RS; Zimran A
Am J Med; 2002 Aug; 113(2):112-9. PubMed ID: 12133749
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
Rosenthal DI; Doppelt SH; Mankin HJ; Dambrosia JM; Xavier RJ; McKusick KA; Rosen BR; Baker J; Niklason LT; Hill SC
Pediatrics; 1995 Oct; 96(4 Pt 1):629-37. PubMed ID: 7567322
[TBL] [Abstract][Full Text] [Related]
8. Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy.
Schiffmann R; Mankin H; Dambrosia JM; Xavier RJ; Kreps C; Hill SC; Barton NW; Rosenthal DI
Blood Cells Mol Dis; 2002; 28(2):288-96. PubMed ID: 12064924
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease.
Barton NW; Brady RO; Dambrosia JM; Doppelt SH; Hill SC; Holder CA; Mankin HJ; Murray GJ; Zirzow GC; Parker RI
J Pediatr; 1992 Feb; 120(2 Pt 1):277-80. PubMed ID: 1735829
[TBL] [Abstract][Full Text] [Related]
10. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
[TBL] [Abstract][Full Text] [Related]
11. Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.
Mistry PK; Deegan P; Vellodi A; Cole JA; Yeh M; Weinreb NJ
Br J Haematol; 2009 Nov; 147(4):561-70. PubMed ID: 19732054
[TBL] [Abstract][Full Text] [Related]
12. [Gaucher disease with multiple bone necrosis treated by enzyme replacement therapy and pamidronate].
Abe M; Minoguchi M; Jinbo J; Kikuchi Y; Chiba A; Shibata Y; Kogo Y
Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2421-3. PubMed ID: 15624481
[No Abstract] [Full Text] [Related]
13. Enzyme replacement therapy with imiglucerase in a Taiwanese child with type 1 Gaucher disease.
Lin HY; Lin SP; Chuang CK; Wraith JE
J Chin Med Assoc; 2006 May; 69(5):228-32. PubMed ID: 16835986
[TBL] [Abstract][Full Text] [Related]
14. Low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease.
Cohen IJ; Katz K; Kornreich L; Horev G; Frish A; Zaizov R
Blood Cells Mol Dis; 1998 Sep; 24(3):296-302. PubMed ID: 10087987
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy after avascular necrosis of the femur complicating Gaucher's disease.
Cleary JE; Burke WM; Baxi LV
Am J Obstet Gynecol; 2001 Jan; 184(2):233-4. PubMed ID: 11174510
[TBL] [Abstract][Full Text] [Related]
16. Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.
Heitner R; Arndt S; Levin JB
S Afr Med J; 2004 Aug; 94(8):647-51. PubMed ID: 15352589
[TBL] [Abstract][Full Text] [Related]
17. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
Drelichman G; Ponce E; Basack N; Freigeiro D; Aversa L; Graciela E; Kohan R
J Pediatr; 2007 Aug; 151(2):197-201. PubMed ID: 17643778
[TBL] [Abstract][Full Text] [Related]
18. Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement.
Lebel E; Elstein D; Peleg A; Reinus C; Zimran A; Amir G
Am J Clin Pathol; 2013 Jul; 140(1):91-6. PubMed ID: 23765538
[TBL] [Abstract][Full Text] [Related]
19. Low-dose low-frequency imiglucerase as a starting regimen of enzyme replacement therapy for patients with type I Gaucher disease.
Elstein D; Abrahamov A; Hadas-Halpern I; Meyer A; Zimran A
QJM; 1998 Jul; 91(7):483-8. PubMed ID: 9797931
[TBL] [Abstract][Full Text] [Related]
20. Enzyme replacement therapy for Gaucher disease in Australia.
Goldblatt J; Szer J; Fletcher JM; McGill J; Rowell JA; Wilson M
Intern Med J; 2005 Mar; 35(3):156-61. PubMed ID: 15737135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]